)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Alto Neuroscience
Alto Neuroscience (ANRO) investor relations material
Alto Neuroscience Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary26 Mar, 2026
Executive summary
Annual meeting scheduled for May 12, 2026, with virtual attendance available for shareholders of record as of March 16, 2026.
Shareholders are encouraged to review proxy materials online before voting and can request paper or email copies if desired.
Voting matters and shareholder proposals
Election of two Class II Director nominees, Raymond Sanchez, M.D. and Gwill York, to serve until the 2029 Annual Meeting.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026.
Approval of amendments to the 2024 Equity Incentive Plan and 2024 Employee Stock Purchase Plan to treat pre-funded warrants as outstanding shares for share reserve calculations under the "evergreen" feature.
Proxies may vote on other business that arises during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals presented.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Alto Neuroscience
- Shareholders will vote on director elections, auditor ratification, and key equity plan amendments.ANRO
Proxy filing26 Mar 2026 - ALTO-207 advances in TRD with rapid titration, strong efficacy, and key pipeline catalysts ahead.ANROStifel 2026 Virtual CNS Forum17 Mar 2026
- Biomarker-driven CNS drug portfolio advances multiple late-stage trials with strong financial runway.ANROCorporate presentation16 Mar 2026
- ALTO-207 acquisition and robust cash support multiple pivotal trials through 2028.ANROQ4 202516 Mar 2026
- Lead programs in depression and schizophrenia advance with biomarker-driven trials and pivotal data ahead.ANROTD Cowen 46th Annual Health Care Conference3 Mar 2026
- Phase IIb data for a precision biomarker-driven depression therapy expected in late 2024.ANROJefferies 2024 Global Healthcare Conference1 Feb 2026
- ALTO-100 targets MDD with poor cognition; Phase 2b data expected Oct. 2024, strong market interest.ANROInvestor Day 202421 Jan 2026
- Precision neuroscience trials use digital biomarkers to target and treat subpopulations in depression.ANRO2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- Precision biomarker-driven CNS pipeline targets major unmet needs with multiple late-stage trials.ANROCorporate presentation14 Jan 2026
Next Alto Neuroscience earnings date
Q1 202614 May, 2026
Alto Neuroscience
Next Alto Neuroscience earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage